Accredited Consultant Accredited Consultant Accredited Consultant
Gautam Budh Nagar, Noida
(Mon - Sat)
Accredited Consultant Accredited Consultant Accredited Consultant

India mandates faster reporting of drug side effects

India’s drug regulator has drastically advanced timelines and tightened guidelines for reporting harmful effects of experimental drugs and treatments in efforts to improve oversight of the country’s pharmaceutical industry.

Companies authorised to market medicines must report any serious adverse effects caused by a drug or treatment—such as death, disability or a life-threatening condition—within 15 calendar days of receiving such information.

Mint Poll

Other harmful reactions to an investigational drug or a pharmaceutical product must be reported in 90 calendar days, as per the latest pharmacovigilance guidance document released by the Drugs Controller General of India (DCGI). Mint has seen a copy of the document.

Adverse effects due to poor efficacy of a drug or medication error must also be reported to the authorities, according to the latest document.

The new rules come into effect from 1 February.

DGCI rules already require manufacturers, importers, and marketers of pharmaceutical products in India to report adverse events involving experimental drugs and treatments administered to patients after obtaining their consent. These reports have to be submitted to the Indian Pharmacopoeia Commission (IPC) and the Central Drugs Standard Control Organization (CDSCO).

Per Pubmed, a medical journal, 77 adverse drug reactions were reported in India last year—30.55% higher than in the year before. Till September this year, about 10 cases of adverse drug reactions were reported.

A spokesperson for the health ministry did not reply to queries sent on Thursday.

A uniform system

The latest pharmacovigilance document aims to strengthen the pharmacovigilance system of marketing authorization holders, said Dr Rajiv Singh Raghuvanshi, secretary-cum-scientific director, IPC, in a communication to all stakeholders dated 11 November. Marketing authorization holders, which are allowed to distribute and sell medicines, are also responsible for ensuring a drug’s safety, effectiveness, and quality, as well as complying with regulatory requirements.

3 Comments

  • Riva Collins

    November 9, 2019 - 2:07 am

    It’s no secret that the digital industry is booming. From exciting startups to need ghor
    global and brands, companies are reaching out.

  • Obila Doe

    November 9, 2019 - 2:09 am

    It’s no secret that the digital industry is booming. From exciting startups to need ghor hmiu
    global and brands, companies are reaching out.

    • Riva Collins

      November 9, 2019 - 2:09 am

      It’s no secret that the digital industry is booming. From exciting startups to need ghor hmiu global and brands, companies are reaching out.

Leave A Comment

Choose Demos Submit a Ticket Purchase Theme

Pre-Built Demos Collection

Consultio comes with a beautiful collection of modern, easily importable, and highly customizable demo layouts. Any of which can be installed via one click.

Cryptocurrency
Business Construction
Business Coach
Consulting
Immigration
Finance 2
Corporate 1
Corporate 2
Corporate 3
Consulting
Business 1
Business 2
Business 3
IT Solution
Tax Consulting
Human Resource
Life Coach
Marketing
Insurance
Finance RTL
Marketing
Consulting
Consulting